Help us reach $1,000,000! Match My Donation
Working to make a difference in the lives of all affected by cancer.
Learn About Our Work
Explore immunotherapy discoveries, treatment approvals and milestones.
See Our Breakthroughs
Find clinical trials that match your diagnosis, stage and treatment history.
Learn more about this revolutionary cancer treatment.
Understand the Basics
Meet the CRI scientists committed to the development of immunotherapy.
Ludwig and CRI have launched clinical trials evaluating an immunotherapy for the treatment of the brain cancer glioblastoma multiforme (GBM), and a combination of immunotherapies for a variety of solid tumors.
CRI is proud to announce new features to TheAnswerToCancer.org (TheA2C), a first-of-its-kind website and online community devoted specifically to cancer immunotherapy.
Murdo Gordon of Bristol-Myers Squibb and CRI Trustee Jacques C. Nordeman will receive the Oliver R. Grace Award at Cancer Research Institute’s 28th Annual Awards Dinner.
The nonprofits announced an agreement with VentiRx Pharmaceuticals Inc., a clinical stage biopharmaceutical company, to conduct a clinical trial with motolimod (VTX-2337) combined with other immunotherapy agents through other industry partnerships.
CRI announces launch of a first-of-its-kind website devoted to cancer immunotherapy, designed specifically for cancer patients and their caregivers, TheAnswerToCancer.org.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Trusted consumer watchdog organizations make it a little easier to decide where to give this holiday season with lists of reputable charitable organizations.
Jeopardy! host Alex Trebek will make a special announcement on Tuesday, November 7th.